WNK1 and malignant colon neoplasm: Moreover, this miRNA was found to have an antiangiogenic effect by targeting a serine/threonine-protein kinase known as lysine deficient protein kinase 1 (WNK1), and also inhibiting cell proliferation and inducing cell cycle arrest in colon cancer [79].